-
Synpromics Granted Key Patent in Synthetic Promoter Development
Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce it has been granted a key patent (EP2668277B1) by the European Patent Office
-
ACRI Signs Non-Exclusive License Agreement with BioVendor for liquid biopsy enabling technology
Moncton, Canada, 15th March 2017 / Sciad Newswire / The Atlantic Cancer Research Institute (ACRI) is pleased to announce an agreement with BioVendor – Laboratorní medicína a.s. to license its patented intellectual property for the use of the Vn96 synthetic peptide in liquid biopsy applications. The agreement gives BioVendor non-exclusive rights to use the Vn96 peptide for…
-
Building a Biotech Brand
Wherever your business sits in the bioscience ecosystem, the brand is the foundation of your company’s reputation and it’s as important for businesses in the bioscience sector as in any other.
-
Cypralis Limited Announces Grant Award from Alzheimer’s Drug Discovery Foundation
Cypralis, a life sciences company focussed on the discovery of therapeutics, has been awarded funding of $524,000 by the Alzheimer’s Drug Discovery Foundation (ADDF).
-
JAMA Psychiatry Meta-Analysis Confirms Deprexis Efficacy
Hamburg, Germany, 27th February 2017 / Sciad Newswire / GAIA AG, a global pioneer in digital therapy, announced today that deprexis®, a web-based EC- and FDA-cleared medical device developed by GAIA, has once again been proven to be effective in a global scientific study. A new meta-analysis of individual patient data, published in the latest issue of JAMA Psychiatry,…
-
Cambridge Research Biochemicals® launches second catalogue: DISCOVERY® Antibodies to the Life Science Community
Cambridge Research Biochemicals® (CRB) today announced the release of its new DISCOVERY® Antibodies catalogue.
-
Biosys Appoints Axel Wiest to Board of Directors
Biosys is pleased to announce that Axel Wiest, M.D., Ph.D., M.P.H., has joined the board of the Company.
-
Selcia, Cypralis and Gilead Publish Synthetic Macrocyclic Cyclophilin Inhibitors Inspired by Natural Product Sanglifehrin A
Selcia, with colleagues from Cypralis and Gilead Sciences Inc., have published in the Journal of Medicinal Chemistry a novel strategy to generate synthetically tractable cyclophilin inhibitors for the treatment of HCV.
-
Healthcare Innovation being Sparked by Plastic Electronics – New Report
Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for healthcare innovators to adopt plastic electronics and revolutionise healthcare monitoring and diagnosis. InnovationDB, the world’s largest IP licensable technology database, has carried out a comprehensive study of the use of plastic electronics in healthcare devices to spot the biggest trends and identify the…
-
Plastic Electronics set to Revolutionise Consumer Electronics – New Report
Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for the consumer electronics industry to adopt plastic electronics as new devices are set to revolutionise parts of the industry. Benefits will include significantly lower costs, less material waste, lower energy consumption during manufacture, novel physical properties and increased sustainability. InnovationDB, the world’s…